• 1
    Levy, D., Larson, MG, Vasan, RS, Kannel, WB, Ho, KK (1996) The progression from hypertension to congestive heart failure. JAMA 275: 15571562.
  • 2
    Schunkert, H. (2002) Obesity and target organ damage: the heart. Int J Obes Relat Metab Disord. 26: (Suppl 4), S15S20.
  • 3
    Ford, ES, Giles, WH, Dietz, WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356359.
  • 4
    Ho, SC, Chen, YM, Woo, JL, Leung, SS, Lam, TH, Janus, ED (2001) Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord. 25: 16891697.
  • 5
    Kremer, D., Lindop, G., Brown, WC, Morton, JJ, Robertson, JI (1981) Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure. Cardiovasc Res. 15: 4346.
  • 6
    Gavras, H., Brown, JJ, Lever, AF, MacAdam, RF, Robertson, JIS (1971) Acute renal failure, tubular necrosis and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet ii: 1922.
  • 7
    Gavras, H., Kramer, D., Brown, JJ, et al. (1975) Angiotensin and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J. 89: 321332.
  • 8
    Giacomelli, F., Anversa, P., Wiener, J. (1976) Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol. 84: 111138.
  • 9
    Sharma, AM, Janke, J., Gorzelniak, K., Engeli, S., Luft, FC (2002) Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 40: 609611.
  • 10
    Engeli, S., Schling, P., Gorzelniak, K., et al. (2003) The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol. 35: 807825.
  • 11
    de Cavanagh, EMV, Inserra, F., Toblli, JE, Stella, I., Fraga, C., Ferder, L. (2001) Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38: 11301136.
  • 12
    Unger, T., Li, J. (2004) The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst. 5: (Suppl 1) S7S10.
  • 13
    Lassila, M., Davis, BJ, Allen, TJ, Burrell, LM, Cooper, ME, Cao, Z. (2003) Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Clin Sci (Lond). 104: 341347.
  • 14
    Grossman, E., Messerli, FH Cardiac effects of calcium antagonist in hypertension. Calcium Antagonists in Clinical Medicine by Murray Epstein 207228. 3rd ed, Hanley & Belfus, Inc Philadelphia, PA.
  • 15
    Manning, WJ, Wei, JY, Katz, SE, Litwin, SE, Douglas, PS (1994) In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol. 266: H1672H1675.
  • 16
    Gardin, JM, Siri, FM, Kitsis, RN, Edwards, JG, Leinwand, LA (1995) Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 76: 907914.
  • 17
    Hoit, BD, Khoury, SF, Kranias, EG, Ball, N., Walsh, RA (1995) In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 77: 632637.
  • 18
    Tanaka, N., Dalton, N., Mao, L., et al. (1996) Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94: 11091117.
  • 19
    DeSimone, S., Devereux, RB, Volpe, M., Camargo, DC, Wallerson, DC, Laragh, JH (1996) Midwall LV mechanics in rats with or without renovascular hypertension: effect of different Na+ intakes. Am J Physiol Heart Circ Physiol. 270: H628H637.
  • 20
    Roth, DM, Swaney, JS, Dalton, ND, Gilpin, EA, Ross, J. Jr (2002) Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol. 282: H2134H2140.
  • 21
    Zhou, YT, Grayburn, P., Karim, A., et al. (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 97: 17841789.
  • 22
    Bray, GA (1977) The Zucker-fatty rat: a review. Fed Proc. 36: 148153.
  • 23
    Kava, R., Greenwood, MR, Johnson, PR (1990) Zucker (fa/fa) rats. ILAR News. 32: 48.
  • 24
    Kurtz, TW, Morris, RC, Pershadsingh, HA (1989) The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13: 896901.
  • 25
    van Zwietenn, PA (1999) Diabetes and hypertension: experimental models for pharmacological studies. Clin Exp Hypertens. 21: 16.
  • 26
    Linz, W., Wohlfart, P., Schoelkens, BA, Becker, RH, Malinski, T., Wiemer, G. (1999) Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension 34: 291295.
  • 27
    Zimmermann, R., Kastens, J., Linz, W., Wiemer, G., Schoelkens, BA, Schaper, J. (1999) Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats. J Mol Cell Cardiol. 8: 14471456.
  • 28
    Toblli, JE, Stella, I., Mazza, ON, Ferder, L., Inserra, F. (2004) Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats. Am J Nephrol. 24: 614623.
  • 29
    Kim, S., Zhan, Y., Izumi, Y., Iwao, H. (2000) Cardiovascular effects of combination of perindopril, candesartan and amlodipine in hypertensive rats. Hypertension 35: 769774.
  • 30
    Litwin, SE, Katz, SE, Morgan, JP, Douglas, PS (1994) Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89: 345354.
  • 31
    Devereux, RB, Alonso, DR, Lutas, EM, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 57: 450458.
  • 32
    Chung, ES, Pelini, S., Aurigemma, GP, Fenton, RA, Dobson, JG, Meyer, TE (1998) Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens. 16: 18131822.
  • 33
    Toblli, JE, DeRosa, G., Rivas, C., et al. (2003) Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats. J Hypertens. 21: 611620.
  • 34
    Janke, J., Engeli, S., Gorzelniak, K., Luft, FC, Sharma, AM (2002) Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin-type 1 receptors. Diabetes 51: 16991707.
  • 35
    Gorzelniak, K., Engeli, S., Janke, J., Luft, FC, Sharma, AM (2002) Hormonal regulation of the human adipose-tissue reninangiotensin system: relationship to obesity and hypertension. J Hypertension 20: 965973.
  • 36
    Park, BH, Lee, Y., Walton, M., Duplomb, L., Unger, RH (2004) Demonstration of reverse fatty acid transport from rat cardiomyocytes. J Lipid Res. 45: 19921999.
  • 37
    Shimabukuro, M., Koyama, K., Chen, G., et al. (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A. 94: 46374641.
  • 38
    Lee, Y., Hirose, H., Zhou, YT, Esser, V., McGarry, JD, Unger, RH (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46: 408413.
  • 39
    Qian, H., Azain, MJ, Hartzell, DL, Baile, CA (1998) Increased leptin resistance as rats grow to maturity. PSEBM. 219: 160165.
  • 40
    Wang, ZW, Pan, WT, Lee, Y., Kakuma, T., Zhou, YT, Unger, RH (2001) The role of leptin resistance in the lipid abnormalities of aging. FASEB J. 15: 108114.
  • 41
    Correia, MLG, Haynes, WG (2004) Obesity-related hypertension: is there a role for selective leptin resistance? Curr Hypertens Rep. 6: 230235.
  • 42
    Fruhbeck, G. (1999) Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48: 903908.
  • 43
    Unger, RH, Orci, L. (2001) Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15: 312321.
  • 44
    Hunter, JJ, Chien, KR (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 341: 12761283.
  • 45
    Gealekman, O., Abassi, Z., Rubinstein, I., Winaver, J., Binah, O. (2002) Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 105: 236243.
  • 46
    Ren, J., Sowers, JR, Walsh, MF, Brown, RA (2000) Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol. 279: H1708H1714.
  • 47
    Ren, J., Walsh, MF, Jefferson, L., et al. (2000) Basal and ethanol-induced cardiac contractile response in lean and obese Zucker rat hearts. J Biomed Sci. 7: 390400.
  • 48
    Wold, LE, Relling, DP, Duan, J., Norby, FL, Ren, J. (2002) Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway. Hypertension 39: 6974.
  • 49
    Ren, J., Walsh, MF, Hamaty, M., Sowers, JR, Brown, RA (1998) Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2[thorn] and NO. Am J Physiol. 275: H823H830.
  • 50
    Vincent, HK, Powers, SK, Stewart, DJ, Shanely, RA, Demirel, H., Naito, H. (1999) Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord. 23: 6774.
  • 51
    Unger, RH (1998) How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab. 7: 276282.
  • 52
    Shimabukuro, M., Zhou, YT, Levi, M., Unger, RH (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A. 95: 24982502.
  • 53
    Obeid, LM, Linardic, CM, Karolak, LA, Hannun, YA (1993) Programmed cell death induced by ceramide. Science 259: 17691771.
  • 54
    Zhou, MS, Jaimes, EA, Raij, L. (2004) Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens. 17: 167171.
  • 55
    Ganafa, AA, Walton, M., Eatman, D., Abukhalaf, IK, Bayorh, MA (2004) Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens. 17: 743748.
  • 56
    Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J., Asada, A. (2004) Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy. J Am Coll Cardiol. 43: 21162123.
  • 57
    Varin, R., Mulder, P., Tamion, F., et al. (2000) Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation 102: 351356.
  • 58
    Inserra, F., Romano, L., Ercole, L., de Cavanagh, EM, Ferder, L. (1995) Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension 25: 437442.
  • 59
    de Cavanagh, EM, Fraga, CG, Ferder, L., Inserra, F. (1997) Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol. 272: R514R518.
  • 60
    de Cavanagh, EMV, Inserra, F., Ferder, L., Fraga, CG (2000) Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissue. Am J Physiol. 278: R572R577.
  • 61
    Toblli, JE, Ferder, L., Stella, I., Angerosa, M., Inserra, F. (2002) Enalapril prevents fatty liver in nephrotic rats. J Nephrology 15: 358367.